← Open Payments lookup

STEVEN EPPERSON: Open Payments

NPI 1053074138 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$776 in 36 payments from 11 companies in 2025. Trend: 2023 $162 · 2024 $463 · 2025 $776

Food & beverage: $776
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.7$162
Alkermes, Inc.6$114
Vanda Pharmaceuticals Inc.3$86
Otsuka America Pharmaceutical, Inc.4$84
E.R. Squibb & Sons, L.L.C.4$73
Teva Pharmaceuticals USA, Inc.4$67
Janssen Pharmaceuticals, Inc2$63
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$63
Indivior Inc.1$27
ABBVIE INC.1$24

Products named: INGREZZA, ARISTADA, FANAPT, ABILIFY ASIMTUFII, COBENFY, INVEGA SUSTENNA, CAPLYTA, AUSTEDO XR.

Industry payments across AZ — which companies pay providers there.